Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Adicionar filtros








Intervalo de ano
1.
Indian J Med Ethics ; 2019 JUL; 4(3): 253
Artigo | IMSEAR | ID: sea-195238

RESUMO

Response of the authors to the Letter “Concerns with regard to an article” published online on April 5, 2019 (DOI: 10.20529/IJME.2019.014) on the IJME website.

2.
Indian J Med Ethics ; 2019 JUL; 4(3): 234-237
Artigo | IMSEAR | ID: sea-195229

RESUMO

The Controlled Human Infection Model or CHIM, sometimes described as a human challenge study, is a relatively specialised medical research technique. Researchers infect healthy participants with a weakened strain of a pathogen in a controlled setting, in order to learn more about the infection and the disease, or to develop new vaccines for that disease. Unlike in other human clinical trials, where participants face a risk of harm because of, for example, the drug’s side effects, healthy participants in CHIM trials are deliberately harmed through infection – contrary to every principle and guideline of medical practice and research.

3.
Indian J Med Ethics ; 2018 OCT; 3(4): 292
Artigo | IMSEAR | ID: sea-195139

RESUMO

In recent times there has been an emerging interest in conducting Controlled Human Infection Model studies in low-and-middle-income countries, in which healthy human beings are infected with weakened pathogen strains under controlled conditions. These volunteers are monitored closely so that cures and prevention methods can be developed for the disease. Such studies call into question the legal sophistry of taking consent to harm a person by justifying it for the greater good or advancement of science. This paper analyses the law on the subject and the ethics of obtaining consent to harm another human being as in the context of Controlled Human Infection Models.

4.
Indian J Med Ethics ; 2016 Jul-Sept; 1 (3): 134-137
Artigo em Inglês | IMSEAR | ID: sea-180251

RESUMO

In early May 2016, reports of a bizarre study to attempt a reversal of brain death made the headlines, but there was not even a squeak from the authorities. The “Reanima Project” is a collaboration between an Indian surgeon, Himanshu Bansal, and a US-based biotech company, Bioquark Inc. The research will be conducted by Bansal’s own biotech company, Revita Life Sciences, at his Anupam hospital in Rudrapur, a city in Uttarakhand state.

5.
Indian J Med Ethics ; 2015 Jul-Sept; 12 (3):126-128
Artigo em Inglês | IMSEAR | ID: sea-180108

RESUMO

n April 2015, the Union Cabinet approved the Juvenile Justice (Care and Protection of Children) Bill, 2014, which proposes to bring about regressive changes in the law, that would not only be unconstitutional but also unethical. In May 2015, the Ministry of Women and Child Development introduced the Bill in the Lok Sabha, where it was passed. If the Rajya Sabha, passes the Bill and the President gives his assent to it, the youth of this country will be harmed in a manner that could break the very fabric of the nation.

6.
Indian J Med Ethics ; 2014 Apr-June ; 11(2): 117-120
Artigo em Inglês | IMSEAR | ID: sea-153538

RESUMO

On September 13, 2013, the Supreme Court absolved Dr Praful Desai, an oncologist, of conviction on the charge of criminal medical negligence in the treatment of one of his patients. This article examines the judgment of the Supreme Court in the light of medical negligence and criminal jurisprudence.


Assuntos
Adulto , Crime/legislação & jurisprudência , Feminino , Humanos , Índia , Responsabilidade Legal , Imperícia/legislação & jurisprudência , Erros Médicos/legislação & jurisprudência , Oncologia/legislação & jurisprudência , Pessoa de Meia-Idade , Má Conduta Profissional/legislação & jurisprudência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA